The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...
主要な著者: | Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D |
---|---|
フォーマット: | Conference item |
出版事項: |
Springer London
2018
|
類似資料
-
The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
著者:: Ali, M, 等
出版事項: (2018) -
Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
著者:: Ali, MS, 等
出版事項: (2017) -
Oral bisphosphonates and chronic kidney disease: progression and safety
著者:: Prieto-Alhambra, D, 等
出版事項: (2018) -
Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
著者:: Alarkawi, D, 等
出版事項: (2018) -
Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
著者:: Robinson, DE, 等
出版事項: (2021)